> To put it much more simply, there is nothing that a 6-year-old would consider “invented” about the patentable cDNA.
That's the point. Patent law is very suitable for processes that cost millions to develop, but in pharmaceutics the big cost factor isn't process development, it is the discovery. What Myriad did is identify the gene, that is where the cost was sunk that they somehow have to recover.
But since you can patent only things, and not intellectual property, the Supreme Court had to resort to all kinds of legal hacks of the sort that judges hate to see applied in their courtroom.